Ocuphire Pharma Results

Baseline Characteristics for ZETA-1 Trial (Continued) DRSS Scores in Diabetic Study Population Ocuphire PHARMA Parameter Study Eye DRSS n(%) Fellow Eye DRSS n(%) Total N = 103 Source: ZETA-1 Demographics and Baseline Characteristics DRSS 47 (Moderately Severe NPDR) DRSS 53 (Severe NPDR) DRSS 61 (Mild PDR) DRSS 20-40 (Mild to Moderate NPDR) DRSS 47 (Moderately Severe NPDR) DRSS 53 (Severe NPDR) DRSS 61 (Mild PDR) DRSS 65-85 (Moderate to Severe PDR) Not Graded Note: 15 fellow eyes were CST>320 microns (center-involved DME eyes) 39 (38%) 53 (52%) 11 (11%) 29 (28%) 34 (33%) 22 (21%) 5 (5%) 11 (11%) 2 (2%) 46

View entire presentation